Detalhe da pesquisa
1.
Hereditary cancer risk assessment and genetic testing in the community urology practice setting.
Prostate
; 82(7): 850-857, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239202
2.
Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer.
J Urol
; 195(3): 612-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26403586
3.
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
Bioorg Med Chem Lett
; 20(5): 1677-9, 2010 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20137940
4.
Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
Cancer Epidemiol Biomarkers Prev
; 26(7): 1107-1113, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28377414
5.
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.
Oncotarget
; 7(23): 35241-56, 2016 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27153551
6.
Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase Mps1.
Mol Cancer Ther
; 10(12): 2267-75, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21980130
7.
Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound.
Chem Biol
; 17(6): 659-64, 2010 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20609415
8.
The protein network of HIV budding.
Cell
; 114(6): 701-13, 2003 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-14505570